Global Biologics and Biosimilars Sales Market Report 2016

Global Biologics and Biosimilars Sales Market Report 2016

1 Biologics and Biosimilars Overview

1.1 Product Overview and Scope of Biologics and Biosimilars

1.2 Classification of Biologics and Biosimilars

1.2.1 Classification by Technology

1.2.2 Classification by Types

1.2.3 Classification by Use

1.2.4 Classification by Services

1.3 Application of Biologics and Biosimilars

1.3.1 Tumor

1.3.2 Diabetes

1.3.3 Cardiovascular

1.3.4 Hemophilia

1.3.5 Other

1.4 Biologics and Biosimilars Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Biologics and Biosimilars (2011-2021)

1.5.1 Global Biologics and Biosimilars Sales and Growth Rate (2011-2021)

1.5.2 Global Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

2 Global Biologics and Biosimilars Competition by Manufacturers, Type and Application

2.1 Global Biologics and Biosimilars Market Competition by Manufacturers

2.1.1 Global Biologics and Biosimilars Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2011-2016)

2.2 Global Biologics and Biosimilars (Volume and Value) by Type

2.2.1 Global Biologics and Biosimilars Sales and Market Share by Type (2011-2016)

2.2.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)

2.3 Global Biologics and Biosimilars (Volume and Value) by Regions

2.3.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2011-2016)

2.3.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2011-2016)

2.4 Global Biologics and Biosimilars (Volume) by Application

3 USA Biologics and Biosimilars (Volume, Value and Sales Price)

3.1 USA Biologics and Biosimilars Sales and Value (2011-2016)

3.1.1 USA Biologics and Biosimilars Sales and Growth Rate (2011-2016)

3.1.2 USA Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

3.1.3 USA Biologics and Biosimilars Sales Price Trend (2011-2016)

3.2 USA Biologics and Biosimilars Sales and Market Share by Manufacturers

3.3 USA Biologics and Biosimilars Sales and Market Share by Type

3.4 USA Biologics and Biosimilars Sales and Market Share by Application

4 China Biologics and Biosimilars (Volume, Value and Sales Price)

4.1 China Biologics and Biosimilars Sales and Value (2011-2016)

4.1.1 China Biologics and Biosimilars Sales and Growth Rate (2011-2016)

4.1.2 China Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

4.1.3 China Biologics and Biosimilars Sales Price Trend (2011-2016)

4.2 China Biologics and Biosimilars Sales and Market Share by Manufacturers

4.3 China Biologics and Biosimilars Sales and Market Share by Type

4.4 China Biologics and Biosimilars Sales and Market Share by Application

5 Europe Biologics and Biosimilars (Volume, Value and Sales Price)

5.1 Europe Biologics and Biosimilars Sales and Value (2011-2016)

5.1.1 Europe Biologics and Biosimilars Sales and Growth Rate (2011-2016)

5.1.2 Europe Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

5.1.3 Europe Biologics and Biosimilars Sales Price Trend (2011-2016)

5.2 Europe Biologics and Biosimilars Sales and Market Share by Manufacturers

5.3 Europe Biologics and Biosimilars Sales and Market Share by Type

5.4 Europe Biologics and Biosimilars Sales and Market Share by Application

6 Japan Biologics and Biosimilars (Volume, Value and Sales Price)

6.1 Japan Biologics and Biosimilars Sales and Value (2011-2016)

6.1.1 Japan Biologics and Biosimilars Sales and Growth Rate (2011-2016)

6.1.2 Japan Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

6.1.3 Japan Biologics and Biosimilars Sales Price Trend (2011-2016)

6.2 Japan Biologics and Biosimilars Sales and Market Share by Manufacturers

6.3 Japan Biologics and Biosimilars Sales and Market Share by Type

6.4 Japan Biologics and Biosimilars Sales and Market Share by Application

7 India Biologics and Biosimilars (Volume, Value and Sales Price)

7.1 India Biologics and Biosimilars Sales and Value (2011-2016)

7.1.1 India Biologics and Biosimilars Sales and Growth Rate (2011-2016)

7.1.2 India Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

7.1.3 India Biologics and Biosimilars Sales Price Trend (2011-2016)

7.2 India Biologics and Biosimilars Sales and Market Share by Manufacturers

7.3 India Biologics and Biosimilars Sales and Market Share by Type

7.4 India Biologics and Biosimilars Sales and Market Share by Application

8 Southeast Asia Biologics and Biosimilars (Volume, Value and Sales Price)

8.1 Southeast Asia Biologics and Biosimilars Sales and Value (2011-2016)

8.1.1 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Biologics and Biosimilars Sales Price Trend (2011-2016)

8.2 Southeast Asia Biologics and Biosimilars Sales and Market Share by Manufacturers

8.3 Southeast Asia Biologics and Biosimilars Sales and Market Share by Type

8.4 Southeast Asia Biologics and Biosimilars Sales and Market Share by Application

9 Global Biologics and Biosimilars Manufacturers Analysis

9.1 Pfizer

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Biologics and Biosimilars Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Roche

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 120 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Amgen

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 142 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 AbbVie

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Sep Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Sanofi

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Johnson & Johnson

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Novo Nordisk

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharmaceuticals Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 Novartis

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 Merck

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 Lilly

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 3sbio

9.12 Changchun high tech

9.13 CP Guojian Pharmacy

9.14 Biotech Pharma

9.15 Gelgen Biopharma

9.16 Sandoz

9.17 Teva

9.18 Hospira

9.19 Mylan

9.20 3sbio

9.21 Changchun high tech

9.22 CP Guojian Pharmacy

9.23 Biotech Pharma

9.24 Gelgen Biopharma

10 Biologics and Biosimilars Maufacturing Cost Analysis

10.1 Biologics and Biosimilars Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Biologics and Biosimilars

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Biologics and Biosimilars Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Biologics and Biosimilars Market Forecast (2016-2021)

14.1 Global Biologics and Biosimilars Sales, Revenue Forecast (2016-2021)

14.2 Global Biologics and Biosimilars Sales Forecast by Regions (2016-2021)

14.3 Global Biologics and Biosimilars Sales Forecast by Type (2016-2021)

14.4 Global Biologics and Biosimilars Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Biologics and Biosimilars

Table Classification of Biologics and Biosimilars

Figure Global Sales Market Share of Biologics and Biosimilars by Type in 2015

Figure Classification by Technology Picture

Figure Classification by Types Picture

Figure Classification by Use Picture

Figure Classification by Services Picture

Table Applications of Biologics and Biosimilars

Figure Global Sales Market Share of Biologics and Biosimilars by Application in 2015

Figure Tumor Examples

Figure Diabetes Examples

Figure Cardiovascular Examples

Figure Hemophilia Examples

Figure Other Examples

Figure USA Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

Figure China Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

Figure India Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

Figure Global Biologics and Biosimilars Sales and Growth Rate (2011-2021)

Figure Global Biologics and Biosimilars Revenue and Growth Rate (2011-2021)

Table Global Biologics and Biosimilars Sales of Key Manufacturers (2011-2016)

Table Global Biologics and Biosimilars Sales Share by Manufacturers (2011-2016)

Figure 2015 Biologics and Biosimilars Sales Share by Manufacturers

Figure 2016 Biologics and Biosimilars Sales Share by Manufacturers

Table Global Biologics and Biosimilars Revenue by Manufacturers (2011-2016)

Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Biologics and Biosimilars Revenue Share by Manufacturers

Table 2016 Global Biologics and Biosimilars Revenue Share by Manufacturers

Table Global Biologics and Biosimilars Sales and Market Share by Type (2011-2016)

Table Global Biologics and Biosimilars Sales Share by Type (2011-2016)

Figure Sales Market Share of Biologics and Biosimilars by Type (2011-2016)

Figure Global Biologics and Biosimilars Sales Growth Rate by Type (2011-2016)

Table Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)

Table Global Biologics and Biosimilars Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Biologics and Biosimilars by Type (2011-2016)

Figure Global Biologics and Biosimilars Revenue Growth Rate by Type (2011-2016)

Table Global Biologics and Biosimilars Sales and Market Share by Regions (2011-2016)

Table Global Biologics and Biosimilars Sales Share by Regions (2011-2016)

Figure Sales Market Share of Biologics and Biosimilars by Regions (2011-2016)

Figure Global Biologics and Biosimilars Sales Growth Rate by Regions (2011-2016)

Table Global Biologics and Biosimilars Revenue and Market Share by Regions (2011-2016)

Table Global Biologics and Biosimilars Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Biologics and Biosimilars by Regions (2011-2016)

Figure Global Biologics and Biosimilars Revenue Growth Rate by Regions (2011-2016)

Table Global Biologics and Biosimilars Sales and Market Share by Application (2011-2016)

Table Global Biologics and Biosimilars Sales Share by Application (2011-2016)

Figure Sales Market Share of Biologics and Biosimilars by Application (2011-2016)

Figure Global Biologics and Biosimilars Sales Growth Rate by Application (2011-2016)

Figure USA Biologics and Biosimilars Sales and Growth Rate (2011-2016)

Figure USA Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

Figure USA Biologics and Biosimilars Sales Price Trend (2011-2016)

Table USA Biologics and Biosimilars Sales by Manufacturers (2011-2016)

Table USA Biologics and Biosimilars Market Share by Manufacturers (2011-2016)

Table USA Biologics and Biosimilars Sales by Type (2011-2016)

Table USA Biologics and Biosimilars Market Share by Type (2011-2016)

Table USA Biologics and Biosimilars Sales by Application (2011-2016)

Table USA Biologics and Biosimilars Market Share by Application (2011-2016)

Figure China Biologics and Biosimilars Sales and Growth Rate (2011-2016)

Figure China Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

Figure China Biologics and Biosimilars Sales Price Trend (2011-2016)

Table China Biologics and Biosimilars Sales by Manufacturers (2011-2016)

Table China Biologics and Biosimilars Market Share by Manufacturers (2011-2016)

Table China Biologics and Biosimilars Sales by Type (2011-2016)

Table China Biologics and Biosimilars Market Share by Type (2011-2016)

Table China Biologics and Biosimilars Sales by Application (2011-2016)

Table China Biologics and Biosimilars Market Share by Application (2011-2016)

Figure Europe Biologics and Biosimilars Sales and Growth Rate (2011-2016)

Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

Figure Europe Biologics and Biosimilars Sales Price Trend (2011-2016)

Table Europe Biologics and Biosimilars Sales by Manufacturers (2011-2016)

Table Europe Biologics and Biosimilars Market Share by Manufacturers (2011-2016)

Table Europe Biologics and Biosimilars Sales by Type (2011-2016)

Table Europe Biologics and Biosimilars Market Share by Type (2011-2016)

Table Europe Biologics and Biosimilars Sales by Application (2011-2016)

Table Europe Biologics and Biosimilars Market Share by Application (2011-2016)

Figure Japan Biologics and Biosimilars Sales and Growth Rate (2011-2016)

Figure Japan Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

Figure Japan Biologics and Biosimilars Sales Price Trend (2011-2016)

Table Japan Biologics and Biosimilars Sales by Manufacturers (2011-2016)

Table Japan Biologics and Biosimilars Market Share by Manufacturers (2011-2016)

Table Japan Biologics and Biosimilars Sales by Type (2011-2016)

Table Japan Biologics and Biosimilars Market Share by Type (2011-2016)

Table Japan Biologics and Biosimilars Sales by Application (2011-2016)

Table Japan Biologics and Biosimilars Market Share by Application (2011-2016)

Figure India Biologics and Biosimilars Sales and Growth Rate (2011-2016)

Figure India Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

Figure India Biologics and Biosimilars Sales Price Trend (2011-2016)

Table India Biologics and Biosimilars Sales by Manufacturers (2011-2016)

Table India Biologics and Biosimilars Market Share by Manufacturers (2011-2016)

Table India Biologics and Biosimilars Sales by Type (2011-2016)

Table India Biologics and Biosimilars Market Share by Type (2011-2016)

Table India Biologics and Biosimilars Sales by Application (2011-2016)

Table India Biologics and Biosimilars Market Share by Application (2011-2016)

Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2011-2016)

Figure Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Biologics and Biosimilars Sales Price Trend (2011-2016)

Table Southeast Asia Biologics and Biosimilars Sales by Manufacturers (2011-2016)

Table Southeast Asia Biologics and Biosimilars Market Share by Manufacturers (2011-2016)

Table Southeast Asia Biologics and Biosimilars Sales by Type (2011-2016)

Table Southeast Asia Biologics and Biosimilars Market Share by Type (2011-2016)

Table Southeast Asia Biologics and Biosimilars Sales by Application (2011-2016)

Table Southeast Asia Biologics and Biosimilars Market Share by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Biologics and Biosimilars Global Market Share (2011-2016)

Table Roche Basic Information List

Table Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Roche Biologics and Biosimilars Global Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Biologics and Biosimilars Global Market Share (2011-2016)

Table AbbVie Basic Information List

Table AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure AbbVie Biologics and Biosimilars Global Market Share (2011-2016)

Table Sanofi Basic Information List

Table Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi Biologics and Biosimilars Global Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Johnson & Johnson Biologics and Biosimilars Global Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novo Nordisk Biologics and Biosimilars Global Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Biologics and Biosimilars Global Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Merck Biologics and Biosimilars Global Market Share (2011-2016)

Table Lilly Basic Information List

Table Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Lilly Biologics and Biosimilars Global Market Share (2011-2016)

Table 3sbio Basic Information List

Table 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure 3sbio Biologics and Biosimilars Global Market Share (2011-2016)

Table Changchun high tech Basic Information List

Table Changchun high tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Changchun high tech Biologics and Biosimilars Global Market Share (2011-2016)

Table CP Guojian Pharmacy Basic Information List

Table CP Guojian Pharmacy Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure CP Guojian Pharmacy Biologics and Biosimilars Global Market Share (2011-2016)

Table Biotech Pharma Basic Information List

Table Biotech Pharma Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Biotech Pharma Biologics and Biosimilars Global Market Share (2011-2016)

Table Gelgen Biopharma Basic Information List

Table Gelgen Biopharma Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Gelgen Biopharma Biologics and Biosimilars Global Market Share (2011-2016)

Table Sandoz Basic Information List

Table Sandoz Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sandoz Biologics and Biosimilars Global Market Share (2011-2016)

Table Teva Basic Information List

Table Teva Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Teva Biologics and Biosimilars Global Market Share (2011-2016)

Table Hospira Basic Information List

Table Hospira Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Hospira Biologics and Biosimilars Global Market Share (2011-2016)

Table Mylan Basic Information List

Table Mylan Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Mylan Biologics and Biosimilars Global Market Share (2011-2016)

Table 3sbio Basic Information List

Table 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure 3sbio Biologics and Biosimilars Global Market Share (2011-2016)

Table Changchun high tech Basic Information List

Table Changchun high tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Changchun high tech Biologics and Biosimilars Global Market Share (2011-2016)

Table CP Guojian Pharmacy Basic Information List

Table CP Guojian Pharmacy Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure CP Guojian Pharmacy Biologics and Biosimilars Global Market Share (2011-2016)

Table Biotech Pharma Basic Information List

Table Biotech Pharma Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Biotech Pharma Biologics and Biosimilars Global Market Share (2011-2016)

Table Gelgen Biopharma Basic Information List

Table Gelgen Biopharma Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Gelgen Biopharma Biologics and Biosimilars Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biologics and Biosimilars

Figure Manufacturing Process Analysis of Biologics and Biosimilars

Figure Biologics and Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015

Table Major Buyers of Biologics and Biosimilars

Table Distributors/Traders List

Figure Global Biologics and Biosimilars Sales and Growth Rate Forecast (2016-2021)

Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Table Global Biologics and Biosimilars Sales Forecast by Regions (2016-2021)

Table Global Biologics and Biosimilars Sales Forecast by Type (2016-2021)

Table Global Biologics and Biosimilars Sales Forecast by Application (2016-2021)